Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich to Commercialize Cyntellect s CellXpress Services

NEW YORK , April 27 (GenomeWeb News) -  Sigma Aldrich will market Cyntellect's CellXpress services to biopharmaceutical markets served by the SAFC/JRH Biopharma unit, the companies said today. 

 

CellXpress, a service for isolating high- titer cells for production of biotherapeutics, will provide "access to state-of-the-art technology" and a "clear competitive advantage" to SAFC/JRH customers, according to Carl Schrott, the biopharma unit's strategic marketing manager.

 

Schrott credited CellXpress with having the abilities to enable the "cloning of cell lines that secrete significantly greater amounts of protein than cell lines" than competitive technology in "a shorter amount of time." 

 

Financial details were not discussed.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.